en

PRODUCT DETAIL

Eslibon 200 mg tablety

Code 9374C
MA number 21/0340/18-S
Product Form: tbl 28x200 mg (blis.PVC/Al-nepriehľad.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 21 - ANTIEPILEPTICA, ANTICONVULSIVA
ATC:
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AF Carboxamide derivatives
N03AF04 Eslicarbazepine
Shelf life: 36
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.10.2018
Pediatric indication: Yes
Pediatric posology: Yes
PIL: PIL_Eslibon 08.2022.pdf  
SPC: SPC_Eslibon_08.2022.pdf  
Safety feature Yes
Data update: 26.01.2023
eu-flag.png sk-flag.png